Health & Biotech
Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.
Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use.
Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Stockhead TV
Investor Presentation: Osteopore (ASX:OSX)
Health & Biotech
Osteopore is a step closer to the huge Chinese market after signing a distribution deal
Health & Biotech
Health Kick Podcast: How Osteopore is innovating in the area of bone and tissue regeneration
News
Closing Bell: Small Caps have punched well above their weight today
Health & Biotech
Bone and tissue regeneration specialist Osteopore gains access to US Federal healthcare facilities
Health & Biotech
Leading Aussie medtechs Osteopore and Singular Health reveal landmark deal
Health & Biotech
Onwards and upwards for Osteopore as record growth builds momentum
Health & Biotech
Osteopore delivers three straight quarters of growth in record financial performance
Health & Biotech
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit
News
Closing Bell: Australia lifts small cap rate by 2%
News
ASX Small Caps Lunch Wrap: Who else is hitting the creepy tech panic button today?
Health & Biotech
Osteopore hard at work on the next generation of its 3D-printed bioresorbable implants with focus on the large orthopaedic market
Health & Biotech
Osteopore’s moves to reduce post-surgery complications with 3D-printed bioresorbable implants
Health & Biotech
Osteopore signs key collaboration to get a lift from orthopaedics
Health & Biotech
We’re gonna hear them roar, Osteopore deal to enter South Africa sees it with presence on every continent
Health & Biotech
Bone specialist Osteopore secures key ANZ distribution as it targets oral & maxillofacial surgery
News